Suppr超能文献

功能性便秘与肠道微生物群的关系:益生元的影响综述。

Functional constipation and the effect of prebiotics on the gut microbiota: a review.

机构信息

School of Pharmacy, The University of Queensland, Brisbane, QLD4102, Australia.

School of Pharmacy, The University of Sydney, Camperdown, NSW2006, Australia.

出版信息

Br J Nutr. 2023 Sep 28;130(6):1015-1023. doi: 10.1017/S0007114522003853. Epub 2022 Dec 2.

Abstract

Functional constipation is a significant health issue impacting the lives of an estimated 14 % of the global population. Non-pharmaceutical treatment advice for cases with no underlying medical conditions focuses on exercise, hydration and an increase in dietary fibre intake. An alteration in the composition of the gut microbiota is thought to play a role in constipation. Prebiotics are non-digestible food ingredients that selectively stimulate the growth of a limited number of bacteria in the colon with a benefit for host health. Various types of dietary fibre, though not all, can act as a prebiotic. Short-chain fatty acids produced by these microbes play a critical role as signalling molecules in a range of metabolic and physiological processes including laxation, although details are unclear. Prebiotics have a history of safe use in the food industry spanning several decades and are increasingly used as supplements to alleviate constipation. Most scientific research on the effects of prebiotics and gut microbiota has focussed on inflammatory bowel disease rather than functional constipation. Very few clinical studies evaluated the efficacy of prebiotics in the management of constipation and their effect on the microbiota, with highly variable designs and conflicting results. Despite this, broad health claims are made by manufacturers of prebiotic supplements. This narrative review provides an overview of the literature on the interaction of prebiotics with the gut microbiota and their potential clinical role in the alleviation of functional constipation.

摘要

功能性便秘是一个重大的健康问题,估计影响了全球 14%的人口。对于没有潜在医疗条件的病例,非药物治疗建议侧重于运动、补水和增加膳食纤维摄入。肠道微生物群组成的改变被认为在便秘中起作用。益生元是不可消化的食物成分,它们选择性地刺激结肠中有限数量的细菌生长,对宿主健康有益。虽然并非所有膳食纤维都可以作为益生元,但各种类型的膳食纤维都可以。这些微生物产生的短链脂肪酸在一系列代谢和生理过程中起着关键的信号分子作用,包括松弛,尽管细节尚不清楚。益生元在食品工业中的安全使用历史已有几十年,并且越来越多地被用作缓解便秘的补充剂。大多数关于益生元和肠道微生物群的科学研究都集中在炎症性肠病上,而不是功能性便秘上。很少有临床研究评估了益生元在便秘管理中的疗效及其对微生物群的影响,而且设计和结果差异很大。尽管如此,益生元补充剂制造商还是提出了广泛的健康声明。本综述概述了关于益生元与肠道微生物群相互作用的文献,并探讨了其在缓解功能性便秘方面的潜在临床作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab7/10442792/6369c2a1289e/S0007114522003853_figAb.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验